BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35775414)

  • 1. Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: A systematic review.
    Ramos-Herrada RM; Arriola-Guillén LE; Atoche-Socola KJ; Bellini-Pereira SA; Castillo AA
    Dent Med Probl; 2022; 59(2):271-280. PubMed ID: 35775414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
    Chen YW; Chiu YW; Chen CY; Chuang SK
    Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Botulinum Toxin in Orofacial Clinical Practice.
    Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD007533. PubMed ID: 25062018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
    Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin in the management of temporomandibular disorders: a systematic review.
    Thambar S; Kulkarni S; Armstrong S; Nikolarakos D
    Br J Oral Maxillofac Surg; 2020 Jun; 58(5):508-519. PubMed ID: 32143934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007533. PubMed ID: 22513950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin in the management of myofascial pain associated with temporomandibular dysfunction.
    Awan KH; Patil S; Alamir AWH; Maddur N; Arakeri G; Carrozzo M; Brennan PA
    J Oral Pathol Med; 2019 Mar; 48(3):192-200. PubMed ID: 30604895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical review of the use of botulinum toxin in orofacial pain disorders.
    Clark GT; Stiles A; Lockerman LZ; Gross SG
    Dent Clin North Am; 2007 Jan; 51(1):245-61, ix. PubMed ID: 17185069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum Toxin Type A for Painful Temporomandibular Disorders: Systematic Review and Meta-Analysis.
    Machado D; Martimbianco ALC; Bussadori SK; Pacheco RL; Riera R; Santos EM
    J Pain; 2020; 21(3-4):281-293. PubMed ID: 31513934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review.
    Ho KY; Tan KH
    Eur J Pain; 2007 Jul; 11(5):519-27. PubMed ID: 17071119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manual Therapy in the Treatment of Myofascial Pain Related to Temporomandibular Disorders: A Systematic Review.
    de Melo LA; Bezerra de Medeiros AK; Campos MFTP; Bastos Machado de Resende CM; Barbosa GAS; de Almeida EO
    J Oral Facial Pain Headache; 2020 Spring; 34(2):141-148. PubMed ID: 32255579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin for Treating Temporomandibular Disorders: What is the Evidence?
    Delcanho R; Val M; Guarda Nardini L; Manfredini D
    J Oral Facial Pain Headache; 2022; 36(1):6-20. PubMed ID: 35298571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Botulinum Toxin for Treatment of Symptomatic Pelvic Floor Myofascial Pain in Women: A Systematic Review and Meta-analysis.
    Meister MR; Brubaker A; Sutcliffe S; Lowder JL
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e152-e160. PubMed ID: 32301801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on botulinum toxin A injections of trigger points for myofascial pain.
    Zhou JY; Wang D
    Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
    Ojala T; Arokoski JP; Partanen J
    Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment of myofascial pain: a critical review of the literature.
    Gerwin R
    Curr Pain Headache Rep; 2012 Oct; 16(5):413-22. PubMed ID: 22777564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular injections of botulinum toxin for the treatment of upper back myofascial pain syndrome: A systematic review of randomized controlled trials.
    Leonardi G; Alito A; Portaro S; Di Matteo B; Respizzi S; Kon E; Massazza G; Sconza C
    Eur J Pain; 2024 Mar; 28(3):369-381. PubMed ID: 37950343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin therapy for myofascial pain disorders.
    Lang AM
    Curr Pain Headache Rep; 2002 Oct; 6(5):355-60. PubMed ID: 12207848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.